2026-04-17T06:03:17Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/2238602025-12-02T07:01:21Zcom_2072_1057col_2072_478858col_2072_478917col_2072_478921

urn:hdl:2445/223860 Thinner and wiser? Prospects of GLP-1 agonists in psychiatry Vieta i Pascual, Eduard, 1963- Oliva, Vincenzo Malalties mentals Cognició Hormones gastrointestinals Humor (Psicologia) Psiquiatria Mental illness Cognition Gastrointestinal hormones Mood (Psychology) Psychiatry In recent years, growing scientific attention has converged on the intricate, bidirectional relationship between physical health and mental well-being. Chronic inflammation, disruptions in the gut–brain axis and microbiota, and metabolic alterations such as obesity and type 2 diabetes have all been implicated in the pathophysiology of neuropsychiatric disorders. These insights are not merely academic—they are transforming how we approach, frame, and treat neuropsychiatric disorders. 2025-10-23T15:47:35Z 2025-05-22 2025-10-23T15:47:35Z info:eu-repo/date/embargoEnd/2026-05-21 info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion Versió postprint del document publicat a: https://doi.org/10.1016/j.euroneuro.2025.05.006 European Neuropsychopharmacology, 2025, vol. 97, p. 3-4 https://doi.org/10.1016/j.euroneuro.2025.05.006 cc-by-nc-nd (c) Elsevier B.V., 2025 http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/embargoedAccess Elsevier B.V. Articles publicats en revistes (Medicina)